Year: 2024

AS Infortar acquires 100% shareholding in AS Tallink Takso

Written by Customer Service on November 8, 2024. Posted in Public Companies.

In the course of the intra-group reorganisation of AS Infortar, on 7 November 2024, AS Tallink Grupp transferred 34,000 shares of AS Tallink Takso with a nominal value of 6.3 euros, representing 34% of the share capital, to AS Infortar. Following the transaction, AS Infortar will hold 100% of the shares in AS Tallink Takso. The transaction is not treated as a transaction beyond everyday economic activities or a transaction of a significant importance. Transaction is between related parties but does not have a significant impact on the activities of AS Infortar or AS Tallink Grupp.Anneli SimmInvestorsuhete juht AS Tallink GruppSadama 510111 TallinnPhone: +372 56157170E-mail Anneli.simm@tallink.ee

Pineapple Energy Announces Distribution to Contingent Value Rights Holders

Written by Customer Service on November 8, 2024. Posted in Dividend Reports And Estimates.

RONKONKOMA, N.Y., Nov. 08, 2024 (GLOBE NEWSWIRE) — Pineapple Energy Inc. (Nasdaq: PEGY) (“Pineapple” or the “Company”), a leading provider of sustainable solar energy and backup power to households, businesses, municipalities, and for servicing existing systems, today announced that it will distribute to the holders of its non-transferable Contingent Value Rights (“CVRs”) a payment of $850,269, or $0.35 per CVR. “Since taking the helm, one of our top priorities has been honoring the trust of our investors. Making good on our commitments means meeting our obligations to CSI shareholders through these CVR distributions,” said Scott Maskin, Interim Chief Executive Officer. “Our new leadership team continues to author a new future for Pineapple Energy, with a focus on elevating our corporate governance, properly aligning our cost structure,...

BEN Appoints Walid Khiari as New CFO and COO, Driving Growth and Innovation

Written by Customer Service on November 8, 2024. Posted in Public Companies.

JACKSON, Wyo., Nov. 08, 2024 (GLOBE NEWSWIRE) — Brand Engagement Network Inc. (“BEN”) (Nasdaq: BNAI), a global leader in secure and reliable conversational AI solutions, proudly announces the appointment of Walid Khiari as Chief Financial Officer (CFO) and Chief Operating Officer (COO), effective November 18, 2024. This strategic leadership addition underscores BEN’s commitment to growth, innovation, and financial excellence.Walid Khiari, newly appointed CFO and COO of Brand Engagement Network Inc. With over 20 years of experience in finance, including 15 years as a technology investment banker advising software companies, from high-growth startups to publicly traded giants, Mr. Khiari brings an unmatched depth of expertise in capital raising, mergers and acquisitions, and strategic planning. His extensive experience with firms...

Plains All American Reports Third-Quarter 2024 Results

Written by Customer Service on November 8, 2024. Posted in Earnings Releases And Operating Results.

HOUSTON, Nov. 08, 2024 (GLOBE NEWSWIRE) — Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) today reported third-quarter 2024 results. Third-Quarter ResultsReported net income attributable to PAA of $220 million and net cash provided by operating activities of $692 millionDelivered solid Adjusted EBITDA attributable to PAA of $659 millionProgressed our efficient growth strategy with a small bolt-on acquisition of a Permian gathering systemExited the quarter with 3.0x leverage ratio, below our target range of 3.25x – 3.75xReceived Moody’s upgrade from Baa3 to Baa2 with stable outlook; now mid-BBB at all three credit rating agenciesResolved remaining material Line 901 claims against Plains with two lawsuit settlements resulting in a $120 million charge to GAAP earnings2024 Guidance...

Rapid Micro Biosystems to Participate in the Stifel 2024 Healthcare Conference

Written by Customer Service on November 8, 2024. Posted in Public Companies.

LEXINGTON, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the Stifel 2024 Healthcare Conference. Rob Spignesi, President and CEO, and Sean Wirtjes, CFO, are scheduled to participate in a 30-minute question-and-answer session with the host analyst on Monday, November 18, 2024 at 11:30 a.m. Eastern Time. A live webcast will be available on the Rapid Micro Biosystems investor relations website at https://investors.rapidmicrobio.com/ and can be accessed here. The webcast will be archived and available for replay after the event. About Rapid Micro...

Vera Therapeutics to Participate at Upcoming Investor Conferences

Written by Customer Service on November 8, 2024. Posted in Public Companies.

BRISBANE, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that the Company’s management team will present and participate in one-on-one meetings at upcoming investor conferences. Investor Conference Details:Guggenheim Securities Healthcare Innovation ConferenceFormat: Fireside Chat and 1x1sWebcast: https://wsw.com/webcast/guggen/vera/1942294Date: Wednesday, November 13, 2024Time: 9:30am ESTLocation: Boston, MA7th Annual Evercore ISI HealthCONx ConferenceFormat: Fireside Chat and 1x1sWebcast: https://wsw.com/webcast/evercore44/vera/2364138Date: Thursday, December 5, 2024Time: 7:55am ESTLocation: Coral Gables, FLA...

ASII’s GlobeTopper Platform: The Numbers That Matter

Written by Customer Service on November 8, 2024. Posted in Public Companies.

NEW YORK, Nov. 08, 2024 (GLOBE NEWSWIRE) — Accredited Solutions, Inc. (OTC: ASII) (“Accredited Solutions” or the “Company”), the parent company of Diamond Creek Water, today shared key facts about its newly acquired GlobeTopper business, showing why this digital gift card company is set for strong growth. The Business in Simple Terms:GlobeTopper helps businesses send digital gift cards to their customers and employees Currently makes $37 million in yearly revenue Works with over 2,700 popular brands like Amazon, Target, and Starbucks Operates in 65 countries worldwide“Think of GlobeTopper as a digital gift card powerhouse,” said Eduardo Brito, CEO of Accredited Solutions. “When a large company wants to reward thousands of employees with holiday gift cards, they use our platform to make...

Oxford Lane Capital Corp. Provides October Net Asset Value Update

Written by Customer Service on November 8, 2024. Posted in Public Companies.

GREENWICH, Conn., Nov. 08, 2024 (GLOBE NEWSWIRE) — Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (NasdaqGS: OXLCI) (the “Company”) today announced the following net asset value (“NAV”) estimate as of October 31, 2024.Management’s unaudited estimate of the range of the NAV per share of our common stock as of October 31, 2024, is between $4.82 and $4.92. This estimate is not a comprehensive statement of our financial condition or results for the month ended October 31, 2024. This estimate did not undergo the Company’s typical quarter-end financial closing procedures and was not approved by the Company’s board of directors. We advise you that our NAV per share for the quarter ending December 31, 2024 may differ materially from this estimate, which...

Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments

Written by Customer Service on November 8, 2024. Posted in Public Companies.

In-licensed ALXN-1840 (a Late-Stage Wilson Disease Drug Candidate) from Alexion, AstraZeneca Rare DiseaseTwo Novel Radiopharma Clinical Trials now Active and Enrolling Patients with Advanced Solid Cancers WILMETTE, Ill., Nov. 08, 2024 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biotechnology company focused on developing innovative treatments for patients with unmet medical needs, today announced third quarter 2024 financial results and summarized recent developments. Recent Developments ALXN-1840 for Wilson disease – Late StageOn October 23, 2024, the Company entered into an exclusive license with Alexion, AstraZeneca Rare Disease whereby the Company gained worldwide rights to develop and commercialize ALXN-1840 (bis-choline tetrathiomolybdate). ALXN-1840 is a drug...

Akari Therapeutics Announces Shareholder Approval in Connection With Peak Bio, Inc. Merger

Written by Customer Service on November 8, 2024. Posted in Mergers And Acquisitions.

BOSTON and LONDON, Nov. 08, 2024 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an innovative biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, announces shareholder approval in connection with the merger of Akari Therapeutics, Plc (the Company) and Peak Bio, Inc. At a General Meeting held in relation to the merger at 9:00 a.m. Eastern Time on Thursday, November 7, 2024 at the Company’s offices in London, shareholders approved the Company’s issuance of shares in connection with the proposed merger, with approximately 99% of shares present at the General Meeting, in person or by proxy, voted in support. “I am thrilled to announce this important step toward finalization of the merger of our two companies,” said Samir Patel, MD, Akari’s Interim President & CEO. “With the...

Year: 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals